3Staels B,Dallonggeville J, Schoonjans K,et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998,98 :2088-2093.
二级参考文献8
1Rubins HB,Robins SJ,Collins D,et al.Gemfibrozil for the second prevention of coronary heart disease in men with low levels of highdensity lipoprotein cholesterol.Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Intervention Trial Study Group[].The New England Journal of Medicine.1999
2Sacks FM,Pfeffer MA,Moye LA,et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.Cholesterol and Recurrent Events Trial investigators[].The New England Journal of Medicine.1996
3Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.West of Scotland Coronary Prevention Study Group[].The New England Journal of Medicine.1995
4Kirchgassler KU,Schmitz H,Bach G,et al.Effectiveness and tolerability of 12-week treatment with micronised fenofibrate 200mg in a drug-monitoring programme involving 9884 patients with dyslipidemia[].Clinical Drug Investigation.1998
5Kornitzer M,Dramaix M,Vandenbroek MD,et al.Efficacy and tolerance of 200mg micronized fenofibrate administered over 6-month period in hyperlipidaemic patients: an open Belgian multicenter study[].Atherosclerosis.1994
6Miller M,Seidler A,Kwiterovich PO,et al.Long-term predictors of subsequent cardiovascular events with coronary artery disease and"desirable"levels of plasma total cholesterol[].Circulation.1992
7Auwerx J,Schoonjans K,Fruchart JC,et al.Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apoC-III genes by activating the nuclear receptor PPAR[].Atherosclerosis.1996
8Gordon DJ,Probstfield JL,Garrison RJ,et al.High-density lipoprotein cholesterol and cardiovascular disease.Four prospective American studies[].Circulation.1989
2[4]Castelli WP Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA, 1986,256:2835 - 8.
3Fribouilloy C,Peltier M,Colas L,et al.Fibrinogen is an independent marker for thoracic aortic atherosclerosis.Am J Cordiol,1998,81(3):321.
4Yano K,Grove JS,Chen R,et al.Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men.Arterioscler Thromb Vasc Biol,2001,21(6):1065-1070.
